Thomas J Marrie Selected Research

Pneumonia (Pneumonitis)

09/2008	Mortality reduction with influenza vaccine in patients with pneumonia outside "flu" season: pleiotropic benefits or residual confounding?
09/2006	Factors associated with length of stay in hospital for suspected community-acquired pneumonia.
04/2006	Reasons for coming to hospital after treatment for community-acquired pneumonia on an ambulatory basis.
03/2005	Use of intravenous antibiotics for the treatment of community-acquired pneumonia in the emergency department.
02/2005	Arterial carbon dioxide tension on admission as a marker of in-hospital mortality in community-acquired pneumonia.
01/2004	Experience with levofloxacin in a critical pathway for the treatment of community-acquired pneumonia.
12/2003	Azithromycin in the treatment of Legionella pneumonia requiring hospitalization.
09/2002	Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria.
03/2002	Pneumonia in the long-term-care facility.
02/2002	Community-acquired pneumonia and do not resuscitate orders.

1	Influenza Vaccines (FluMist)IBA 09/2008
1	tebufenozide (Mimic)IBA 05/2008
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2005
1	Carbon DioxideIBA 02/2005
1	Ofloxacin (Levofloxacin)FDA LinkGeneric 01/2004
1	Azithromycin (Zithromax)FDA LinkGeneric 12/2003

1	Length of Stay 09/2006
1	Aftercare (After-Treatment) 04/2006
1	Intensive Care (Surgical Intensive Care) 09/2002
1	Long-Term Care 03/2002
1	Resuscitation Orders (Do Not Resuscitate Orders) 02/2002